Sandoz Group (OTCMKTS:SDZNY) Reaches New 12-Month High – Here’s Why

Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) hit a new 52-week high during trading on Friday . The company traded as high as $63.00 and last traded at $62.78, with a volume of 13410 shares trading hands. The stock had previously closed at $60.73.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on SDZNY shares. Jefferies Financial Group cut Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 8th. Royal Bank Of Canada raised Sandoz Group from a “hold” rating to a “moderate buy” rating in a research note on Friday, May 2nd. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Sandoz Group currently has an average rating of “Hold”.

Sandoz Group Stock Performance

The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.79 and a current ratio of 1.24. The firm’s fifty day simple moving average is $56.77 and its 200 day simple moving average is $49.02.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.